From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

A research program that's paying cash to people who inject drugs is raising concerns for some residents and business owners.

LAHORE: In what appeared to be a distressing incident, a kidney-failure patient died while 30 others contracted Human ...

The National Agency for the Control of AIDS (NACA), on Wednesday, lamented that Ogun State, despite efforts to reduce the ...

A sign for free HIV testing sits in front of JASMYN’s clinic and administration building in Jacksonville. Bob Self/Florida ...

An HIV-positive diagnosis is something people still hide, today. In this film, people in Ireland living with HIV share their ...

Ashok, with HIV infected blood. The alleged incident took place in 2020, when the byelection to R. R. Nagar constituency was ...

A University of New Mexico researcher and assistant professor is breaking barriers in the health community for fellow Native Americans. Hailing from the Diné Nation, Crystal Lee has been researching ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...